Created at 1:17 p.m. Jun, 08, 2024
Author: mohannadkh10
Related Note: 1473986316038 2
Rationale for change

The text says plasma exchange
We had a conversation that they are not the same
Amboss says plasma exchange as well

Extra Extra
Text
What is the treatment for thrombotic thrombocytopenic purpura (TTP)?

{{c1::Plasma exchange}}, {{c2::glucocorticoids}}, {{c3::rituximab}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy Extra
Empty field
Picmonic
Empty field
Physeo

OME

Additional Resources
remove antibodies against ADAM



Emma Holiday:
One by one
Empty field
#AK_Step2_v12::#Subjects::Hematology::01_Hemostasis::01_Primary_Hemostasis::Microangiopathic_Hemolytic_Anemia #PANCE::HEME::coagulation_disorders #AK_Step1_v12::#AMBOSS::36aSkl #PANCE::EOR::IM #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_dorian #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::thrombocytopenia #AK_Step2_v12::Original_decks::Dorian::im::emma #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::thrombocytopenia #AK_Step2_v12::#Resources_by_rotation::IM::emma #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::01_Thrombocytopenia #AK_Step2_v12::#UWorld::COMLEX::101127 #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::04_Thrombotic_Microangiopathies !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-Hematology !AK_UpdateTags::Step2decks::Cheesy-Dorian-(M3)::Internal-Medicine::2-Emma-Holiday-Review #AK_Step1_v12::^Other::^HighYield::4-LowerYield #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::09_Thrombocytopenia #AK_Step2_v12::Original_decks::Dorian::im::uw::heme/onc #AK_Step1_v12::#Pixorize::01_Biochemistry::18_Platelet_Disorders::06_Thrombotic_Thrombocytopenic_Purpura_(TTP) #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::01_Primary_Hemostasis #AK_Step2_v12::#NBME::Form10 #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::02_Bleeding_Disorders:_Platelet_Disorders_DDx #AK_Step2_v12::#UWorld::Step::4339 #AK_Step2_v12::#AMBOSS::PF0WR3 #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::17_Rituximab_Bevacizumab_Alemtuzumab_Cetuximab_Panitumumab_Trastuzmab #AK_Step1_v12::#Pathoma::04_Hemostasis::01_Primary_Hemostasis_&_Related_Bleeding_Disorders #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::01_Autoimmune_disease_therapy::*Rituximab #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::18_Thrombotic_microangiopathies::*Thrombotic_thrombocytopenic_purpura #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::18_Anticancer_monoclonal_antibodies #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::03_Coagulopathies_&_Platelet_Disorders::01_Quantitative_Platelet_Disorders #AK_Step2_v12::#Subjects::Hematology::01_Hemostasis::01_Primary_Hemostasis::Microangiopathic_Hemolytic_Anemia::Thrombotic_Thrombocytopenic_Purpura #PANCE::EOR::PEDS #AK_Step1_v12::#AMBOSS::jF0_33 !AK_UpdateTags::AnKing_Image::Mujeeb::Platelet_disorders #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Step1_v12::#AMBOSS::rmafSO #AK_Step2_v12::#AMBOSS::QF0u33 #AK_Step3_v12::#UWorld::12574 #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::HemeOnc #AK_Step2_v12::#NBME::Form14::Section_3 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::^Other::^EXPN::BGedit !AK_UpdateTags::AnKing_Image::!Subjects::Hematology::Platelet_disorders #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::19_Rituximab #AK_Step1_v12::^Other::^EXPN::Uworld